Most cited papers from TechnoVax (United States)

TechnoVax (United States)

What are the most cited papers from TechnoVax (United States)?

The most cited paper from TechnoVax (United States) is "Zika virus-like particle (VLP) based vaccine" (Hélène Boigard, Alexandra Alimova, George R. Martin et al., 2017), with 162 citations. Next come "Adjuvant formulations for virus-like particle (VLP) based vaccines" (145) and "A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1)" (59).

Published FieldAccess

Showing 13 of 13 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Zika virus-like particle (VLP) based vaccine Hélène Boigard, Alexandra Alimova, George R. Martin et al. · PLoS neglected tropical diseases Open access	8 May 2017	162
2	Adjuvant formulations for virus-like particle (VLP) based vaccines Velasco Cimica, Jose M. Galarza · Clinical Immunology Open access	3 Aug 2017	145
3	A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1) Demetrius Matassov, Albert Cupo, Jose M. Galarza · Viral Immunology	Sep 2007	59
4	Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein Velasco Cimica, Hélène Boigard, Bipin Bhatia et al. · Clinical and Vaccine Immunology Open access	31 Mar 2016	41
5	Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature Hélène Boigard, Velasco Cimica, Jose M. Galarza · Vaccine Open access	28 Oct 2018	37
6	Structural characterization of the PCV2d virus-like particle at 3.3 Å resolution reveals differences to PCV2a and PCV2b capsids, a tetranucleotide, and an N-terminus near the icosahedral 3-fold axes Reza Khayat, Ke Wen, Aleksandra Alimova et al. · Virology Open access	3 Sep 2019	17
7	Current development of Zika virus vaccines with special emphasis on virus-like particle technology Velasco Cimica, Jose M. Galarza, Sujatha Rashid et al. · Expert Review of Vaccines	21 Jun 2021	14
8	Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2 Matthew D. Resch, Ke Wen, Ryan Mazboudi et al. · Vaccines Open access	24 Nov 2022	10
9	A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response Ryan Mazboudi, Hannah Mulhall Maasz, Matthew D. Resch et al. · npj Vaccines Open access	11 Oct 2023	8
10	Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications Ke Wen, Matthew D. Resch, Ryan Mazboudi et al. · Frontiers in Medical Technology Open access	26 Jan 2023	3
11	2009 H1N1 swine flu: the 2010 perspective Doris J. Bucher, Terrence M. Tumpey, Anice C. Lowen et al. · Annals of the New York Academy of Sciences	Sep 2010	2
12	Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient Katherine Reid, Olga Camacho‐Vanegas, Deep S. Pandya et al. · Molecular Case Studies Open access	17 Oct 2023	1
13	ML-driven uterine lavage extracellular vesicle proteomics enables accurate, early detection of endometrial cancer John A. Martignetti et al. · Gynecologic Oncology	23 Apr 2026	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.